ORENSA MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ORENSA MEDICAL
Largest movements
- Cash +€3,062
up €3,062 (+41.1%), from €7,448 to €10,510
mainly Net result for the year (+€7,267) and Tax, wage and social debts (+€332)
- Profit (loss) carried forward +€7,267
up €7,267 (+107%), from €6,813 to €14,081
- Other debts -€4,375
down €4,375 (-98.9%), from €4,424 to €49
- Tax, wage and social debts +€332
up €332 (+18.0%), from €1,850 to €2,182
- Turnover -€20,099
no longer reported in 2025 (was €20,099)
- Purchases and services -€8,436
no longer reported in 2025 (was €8,436)
- Gross operating margin -€1,644
down €1,644 (-14.1%), from €11,663 to €10,019
- Other operating charges +€505
new in 2025: €505
- Taxes +€336
up €336 (+18.2%), from €1,850 to €2,186
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €15,587 | €18,811 | +€3,224 | +20.7% |
| Current assets | 29/58 | €15,587 | €18,811 | +€3,224 | +20.7% |
| Amounts receivable within one year | 40/41 | €8,139 | €8,302 | +€163 | +2.0% |
| Trade receivables | 40 | €8,139 | €8,302 | +€163 | +2.0% |
| Cash at bank and in hand | 54/58 | €7,448 | €10,510 | +€3,062 | +41.1% |
| Total equity and liabilities | 10/49 | €15,587 | €18,811 | +€3,224 | +20.7% |
| Equity | 10/15 | €9,313 | €16,581 | +€7,267 | +78.0% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Contributions outside capital | 11 | €2,500 | - | -€2,500 | |
| Other | 1109/19 | €2,500 | - | -€2,500 | |
| Profit (loss) carried forward | 14 | €6,813 | €14,081 | +€7,267 | +107% |
| Amounts payable | 17/49 | €6,274 | €2,230 | -€4,043 | -64.4% |
| Amounts payable within one year | 42/48 | €6,274 | €2,230 | -€4,043 | -64.4% |
| Taxes, remuneration and social security | 45 | €1,850 | €2,182 | +€332 | +18.0% |
| Taxes | 450/3 | €1,850 | €2,182 | +€332 | +18.0% |
| Other amounts payable | 47/48 | €4,424 | €49 | -€4,375 | -98.9% |
| Turnover | 70 | €20,099 | - | -€20,099 | |
| Goods, raw materials, services and sundry goods | 60/61 | €8,436 | - | -€8,436 | |
| Other operating charges | 640/8 | - | €505 | +€505 | |
| Gross operating margin | 9900 | €11,663 | €10,019 | -€1,644 | -14.1% |
| Operating profit (loss) | 9901 | €11,663 | €9,514 | -€2,149 | -18.4% |
| Financial charges | 65/66B | - | €61 | +€61 | |
| Recurring financial charges | 65 | - | €61 | +€61 | |
| Profit (loss) for the period before taxes | 9903 | €11,663 | €9,453 | -€2,210 | -18.9% |
| Income taxes | 67/77 | €1,850 | €2,186 | +€336 | +18.2% |
| Profit (loss) for the period | 9904 | €9,813 | €7,267 | -€2,546 | -25.9% |
| Profit (loss) for the period to be appropriated | 9905 | €9,813 | €7,267 | -€2,546 | -25.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.